Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Complications of Diabetes Mellitus01:22

Complications of Diabetes Mellitus

Diabetes mellitus is a chronic metabolic disorder characterized by persistent hyperglycemia due to insulin deficiency, resistance, or both. Prolonged hyperglycemia disrupts metabolic homeostasis and leads to acute and chronic complications.Acute ComplicationsAcute complications result from sudden metabolic imbalance.Diabetic ketoacidosis (DKA) mainly appears in type 1 diabetes but may also develop in type 2 diabetes, particularly under extreme stress. It arises from severe insulin deficiency,...
Diabetic Retinopathy01:27

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
Diabetic Neuropathy01:22

Diabetic Neuropathy

DefinitionDiabetic neuropathy is nerve damage caused by long-standing diabetes mellitus. It results directly from prolonged high blood sugar levels.PathophysiologyThe pathophysiology of diabetic neuropathy involves both metabolic and vascular disturbances triggered by chronic hyperglycemia.Metabolic injury: Elevated glucose levels activate the polyol pathway within nerve cells, leading to the accumulation of sorbitol and fructose. This increases oxidative stress, disrupts normal nerve...
Encephalitis l: Introduction01:19

Encephalitis l: Introduction

Encephalitis is inflammation of the brain parenchyma, most often due to infections or autoimmune processes. It presents with neuropsychiatric features such as fever, altered mental status, behavioral changes, cognitive dysfunction, seizures, focal deficits, and sometimes autonomic instability. In some cases, the meninges are also involved, resulting in meningoencephalitis.Infectious CausesInfectious encephalitis is most commonly viral but can also result from bacterial, fungal, or parasitic...
Encephalitis ll: Pathophysiology01:26

Encephalitis ll: Pathophysiology

Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...
Diabetic Ketoacidosis ll: Pathophysiology01:22

Diabetic Ketoacidosis ll: Pathophysiology

Diabetic ketoacidosis (DKA) is a metabolic emergency characterized by hyperglycemia, ketonemia, and metabolic acidosis. It results from severe insulin deficiency and an excess of counterregulatory hormones, leading to uncontrolled lipolysis, ketogenesis, and widespread electrolyte and fluid disturbances.Pathophysiology The central event in DKA is a profound loss of insulin action. Without insulin, glucose uptake in insulin-dependent tissues is impaired, while hepatic glucose production...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mechanisms of diabetic neuropathy: axon dysfunction.

Handbook of clinical neurology·2014
Same author

The clinical potential of C-peptide replacement in type 1 diabetes.

Diabetes·2012
Same author

The identification of gene expression profiles associated with progression of human diabetic neuropathy.

Brain : a journal of neurology·2011
Same author

Insulin and IGF-1 receptors, nitrotyrosin and cerebral neuronal deficits in two young patients with diabetic ketoacidosis and fatal brain edema.

Brain research·2010
Same author

A mutation affecting the sodium/proton exchanger, SLC9A6, causes mental retardation with tau deposition.

Brain : a journal of neurology·2010
Same author

The relevance of C-Peptide in diabetes and its complications: an introduction to the special issue.

The review of diabetic studies : RDS·2009

Related Experiment Video

Updated: Jun 9, 2026

Osmotic Minipump Implantation for Increasing Glucose Concentration in Mouse Cerebrospinal Fluid
06:21

Osmotic Minipump Implantation for Increasing Glucose Concentration in Mouse Cerebrospinal Fluid

Published on: April 7, 2023

Encephalopathies: the emerging diabetic complications.

Anders A F Sima1

  • 1Department of Pathology, Wayne State University, Detroit, MI 48201, USA. asima@med.wayne.edu

Acta Diabetologica
|August 28, 2010
PubMed
Summary

Diabetic encephalopathies present differently in type 1 and type 2 diabetes. Type 2 is linked to Alzheimer's disease risk, while type 1 impacts cognitive functions like memory and learning.

Area of Science:

  • Neuroscience
  • Endocrinology
  • Diabetology

Background:

  • Diabetic encephalopathies are recognized diabetes complications.
  • Type 1 and type 2 diabetes exhibit distinct mechanisms and cognitive deficits.
  • Type 2 diabetes is linked to increased Alzheimer's disease risk due to insulin resistance, hyperglycemia, and associated conditions.

Purpose of the Study:

  • To differentiate the mechanisms and cognitive outcomes of diabetic encephalopathies in type 1 and type 2 diabetes.
  • To explore the link between type 2 diabetes comorbidities and dementia.
  • To discuss the pathobiology of Alzheimer's disease hallmarks in diabetic contexts.

Main Methods:

  • Epidemiological studies examining dementia and Alzheimer's disease incidence in type 2 diabetes.

More Related Videos

Alternate Immersion in Glucose to Produce Prolonged Hyperglycemia in Zebrafish
05:49

Alternate Immersion in Glucose to Produce Prolonged Hyperglycemia in Zebrafish

Published on: May 5, 2021

Related Experiment Videos

Last Updated: Jun 9, 2026

Osmotic Minipump Implantation for Increasing Glucose Concentration in Mouse Cerebrospinal Fluid
06:21

Osmotic Minipump Implantation for Increasing Glucose Concentration in Mouse Cerebrospinal Fluid

Published on: April 7, 2023

Alternate Immersion in Glucose to Produce Prolonged Hyperglycemia in Zebrafish
05:49

Alternate Immersion in Glucose to Produce Prolonged Hyperglycemia in Zebrafish

Published on: May 5, 2021

  • Experimental data analysis on beta-amyloid and tau accumulation.
  • Review of factors contributing to type 1 diabetic encephalopathy, including insulin deficiency and its downstream effects.
  • Main Results:

    • Type 2 diabetes, associated with insulin resistance and hyperglycemia, correlates with increased Alzheimer's disease and dementia.
    • Type 1 diabetic encephalopathy affects learning, intelligence, and memory, impacting academic and professional performance.
    • Impaired central insulin action and insulin deficiency are key in type 1 diabetic encephalopathy, affecting neuronal integrity.

    Conclusions:

    • Diabetic encephalopathies are complex and differ significantly between type 1 and type 2 diabetes.
    • Understanding the pathobiology is advancing, but further research is needed.
    • Intensified investigation is crucial for developing preventive and therapeutic strategies for these diabetes complications.